维普期刊资源整合服务平台（V6.5）

36篇 您的检索式：作者名="Shakespeare A"

选中清除导出查看参考文献查看引证文献引用追踪共2页首页上一页第1页下一页末页 /2 跳转

	题名	作者	年代	出处	被引量
1	Market reac- tions to the disclosure of internal control weaknesses and to the characteristics of those weaknesses under Section 302 of the Sarbanes Oxley Act of 2002显示文摘	Hammersley J S Myers L A Shakespeare C	2008	Review of Ac- counting Studies2008，13，1：	1
2	Market reactions to the disclosure of internal control weaknesses and to the characteristics of those weaknesses under section 302 of the Sarbanes Oxley Act of 2002显示文摘	HAMMERSLEY J S MYERS L A SHAKESPEARE C	2008	Review of Accounting Studies2008，，13：	1
3	Pathology ,diagnosis and pathogenesis of AA amyloidosis 显示文摘	Rocken C Shakespeare A	2002	Virchows Arch2002，440，：	1
4	Market Reac- tions to the Disclosure of Internal Control Weaknesses and to the Characteristics of Those Weaknesses Under Section 302 of the Sarbanes - Oxley Act of 2002 显示文摘	Hammersley J S M A Linda C Shakespeare	2008	Review of Account- ing Studies2008，13，1：	1
5	Prospective phase Ⅱ trial of concomitant boost radiotherapy for stage Ⅱ nasopharyngeal carcinoma: an evaluation of response and toxicity显示文摘	Lu J J Shakespeare T P Thiagarajan A	2005	Laryngoscope2005，115，5：	1
6	Fair value account- ing and gains from asset securitizations: A convenient earn- ings management tool with compensation side-benefits 显示文摘	Dechow P M Myers L A Shakespeare C	2010	Journal of Accounting and Economics2010，49，1：	1
7	Fair Value Ac-counting and Gains from Asset Securitizations : A Conve-nient Earning Management Tool with Compensation Side-Benefits 显示文摘	Dechow P M Myers L A Shakespeare C	2010	Journal of Accounting and Economics2010，49，12：	1
8	MarketReactions to the Disclosure of Internal ControlWeaknesses and to the Characteristics of ThoseWeaknesses Under Section 302 of the Sarbanes Oxley Actof 2002显示文摘	Hammersley J S Myers L A Shakespeare C	2008	Review of Accounting Studies2008，13，：	1
9	Prospective phase II trialof concomitant boost radiotherapy for stage II nasopharyngeal carcino-ma :an evaluation of response and toxicity 显示文摘	Lu JJ Shakespeare TP Thiagarajan A	2005	Laryngoscope2005，115，5：	1
10	Fair val- ue accounting and gains from asset securitizations: a con- venient earnings management tool with compensation side- benefits 显示文摘	DECHOW M P MYERS A L SHAKESPEARE C	2010	Journal of Accounting and Economics2010，49，0102：	1
11	Prospective phase Ⅱ trial of concomitant boost radiotherapy for stage Ⅱ nasopharyn- geal carcinoma: an evaluation of response and toxicity 显示文摘	Lu JJ Shakespeare TP Thiagarajan A	2005	Laryn- goscope2005，115，5：	1
12	Market reactions to the disclosure of internal control weakness and to characteristics of those weaknesses under section 302 of the Sarbanes Oxley Act显示文摘	Hammersley J S Myers L A Shakespeare C	2008	Review of Accounting Study2008，13，1：	1
13	Fair Value Accounting and Gains from Asset Securitizations: A Convenient Earnings Management Tool with Compensation Side-benefits显示文摘	Dechow P M Myers L A Shakespeare C	2010	Journal of Accounting and Economics2010，49，1：	1
14	Fair value accounting and gains from asset securitizations: A convenient earnings management tool with compensation side-benefits 显示文摘	DECI-1OW P M MYERS L A SHAKESPEARE C	2010	Journal of Accounting and Economics2010，49，12：	1
15	Prospective phase Ⅱ trial concomitant boost radiotherapy for stage Ⅱ nasopharyngeal carcinoma:an evaluation of respose and toxicity显示文摘	Shakespeare TP Thiagarajan A	2005	Laryngoscope2005，115，5：	1
16	Pathology, diagnosis and pathogenesis of AA amyloidosis显示文摘	ROCKEN C SHAKESPEARE A	2002	Virchows Arch2002，440，2：	1
17	Market Reactions to the Disclosure of Internal Con- trol Weaknesses and to the Characteristics of ThoseWeaknesses under Section 302 of the Sarbanes Ox- ley Act of 2002显示文摘	Hammersley J S Myers L A Shakespeare C	2007	Review of Accounting Studies2007，13，1：	1
18	Bone-targeted 2,6,9-trisubstituted purines: novel inhibitors of Src tyrosine kinase for the treatment of bone diseases显示文摘	Wang Y Metcalf C A Shakespeare W C	2003	Bioorg Med Chem Lett2003，13，：	1
19	Prospective phase Ⅱ trial of concomitant boost radiotherapy for stage Ⅱ nasopharyngcal carcinoma: an evaluation of response and toxicity 显示文摘	Lu JJ Shakespeare TP Thiagarajan A	2005	Laryngo- scope2005，115，5：	1
20	Prevention of spinal cord injury显示文摘	Von Groote PM Shakespeare T Officer A	2014	Inj Prev2014，20，1：	1

返回顶部每页显示：

共2页首页上一页第1页下一页末页 /2 跳转

互联网出版许可证新出网证(渝)字10号全国400电话 - 免长途话费

用户提示